{"id":367311,"date":"2026-07-13T14:17:49","date_gmt":"2026-07-13T08:47:49","guid":{"rendered":"https:\/\/forumias.com\/blog\/?p=367311"},"modified":"2026-07-13T14:17:49","modified_gmt":"2026-07-13T08:47:49","slug":"awiqli","status":"publish","type":"post","link":"https:\/\/forumias.com\/blog\/awiqli\/","title":{"rendered":"Awiqli"},"content":{"rendered":"<div class=\"content-box-green\">\n<p><b>News: <\/b><span style=\"font-weight: 400;\">Novo Nordisk India announced the launch of Awiqli (insulin icodec), which the company says is the world\u2019s first once-weekly basal insulin for adults with Type 1 or Type 2 diabetes.<\/span><\/p>\n<\/div>\n<h2 class=\"red-h2-box\"><b>About Awiqli<\/b><\/h2>\n<figure id=\"attachment_367313\" aria-describedby=\"caption-attachment-367313\" style=\"width: 244px\" class=\"wp-caption aligncenter\"><img data-recalc-dims=\"1\" loading=\"lazy\" decoding=\"async\" class=\"size-medium wp-image-367313\" src=\"https:\/\/i0.wp.com\/forumias.com\/blog\/wp-content\/uploads\/2026\/07\/Screenshot_13-7-2026_12452_x.com_.jpeg?resize=244%2C300&#038;ssl=1\" alt=\"Awiqli \" width=\"244\" height=\"300\" srcset=\"https:\/\/i0.wp.com\/forumias.com\/blog\/wp-content\/uploads\/2026\/07\/Screenshot_13-7-2026_12452_x.com_.jpeg?resize=244%2C300&amp;ssl=1 244w, https:\/\/i0.wp.com\/forumias.com\/blog\/wp-content\/uploads\/2026\/07\/Screenshot_13-7-2026_12452_x.com_.jpeg?w=552&amp;ssl=1 552w\" sizes=\"auto, (max-width: 244px) 100vw, 244px\" \/><figcaption id=\"caption-attachment-367313\" class=\"wp-caption-text\">Source: PTI<\/figcaption><\/figure>\n<ul>\n<li><b>About: <\/b><span style=\"font-weight: 400;\">Awiqli is the world\u2019s<\/span><b> first once-weekly basal insulin<\/b><span style=\"font-weight: 400;\"> for adults with <strong>Type 1 or Type 2 diabetes. <\/strong><\/span><strong>\u00a0<\/strong><\/li>\n<li><b>Scientific name:<\/b><span style=\"font-weight: 400;\"> Its scientific name is<\/span><b> insulin icodec.\u00a0<\/b><\/li>\n<li><b>How it is used:\u00a0<\/b>\n<ul>\n<li><span style=\"font-weight: 400;\">It is a<\/span><b> prescription-only medicine<\/b><span style=\"font-weight: 400;\"> administered as a <strong>once-weekly subcutaneous injection<\/strong> in the abdomen, thigh, or upper arm, on the same day each week.<\/span><\/li>\n<li><span style=\"font-weight: 400;\">The dose is adjusted based <strong>on regular blood glucose monitoring.<\/strong><\/span>\n<ul>\n<li><span style=\"font-weight: 400;\"><strong>In type 1 diabetes<\/strong>, it must be used with short-acting insulin to cover mealtime insulin needs.<\/span><\/li>\n<li><span style=\"font-weight: 400;\"><strong>In type 2 diabetes<\/strong>, it may be used alone or in combination with other antidiabetic medicines, including short-acting insulin.<\/span><\/li>\n<\/ul>\n<\/li>\n<li><span style=\"font-weight: 400;\">When <\/span><b>switching from another long-acting insulin,<\/b><span style=\"font-weight: 400;\"> the first Awiqli dose may be <\/span><b>increased by 50% to achieve faster blood glucose control; <\/b><span style=\"font-weight: 400;\">this 50% increase is mandatory in type 1 diabetes.<\/span><\/li>\n<\/ul>\n<\/li>\n<li><b>How it works:\u00a0<\/b>\n<ul>\n<li><span style=\"font-weight: 400;\">Diabetes is a disease in which blood glucose is high, either because the body cannot produce insulin (type 1 diabetes) or because the body does not make enough insulin or cannot use it effectively (type 2 diabetes).\u00a0<\/span><\/li>\n<li><span style=\"font-weight: 400;\">The <strong>replacement insulin in Awiqli acts in the same way as the body\u2019s own insulin<\/strong> and<strong> helps glucose enter cells from the blood.<\/strong><\/span><\/li>\n<li><span style=\"font-weight: 400;\">This <strong>controls the level of blood glucose<\/strong> and<strong> reduces the symptoms and complications of diabetes.\u00a0<\/strong><\/span><\/li>\n<li><span style=\"font-weight: 400;\">In the bloodstream<strong>, insulin icodec binds to a protein called albumin<\/strong> which makes it stay longer in the body, prolonging its action.<\/span><\/li>\n<\/ul>\n<\/li>\n<li><b>Benefits:<\/b>\n<ul>\n<li><span style=\"font-weight: 400;\">It was shown<\/span><b> to effectively control blood glucose in five studies<\/b><span style=\"font-weight: 400;\"> involving adults with type 2 diabetes and one study involving adults with type 1 diabetes.<\/span><\/li>\n<li><span style=\"font-weight: 400;\">The main <\/span><b>measure of effectiveness was the change in glycosylated haemoglobin (HbA1c), <\/b><span style=\"font-weight: 400;\">which reflects blood glucose control. Lower HbA1c levels indicate better glucose control.<\/span><\/li>\n<\/ul>\n<\/li>\n<li><b>Complications: <\/b><span style=\"font-weight: 400;\">The most common side effects with <\/span><b>Awiqli (which may affect more than 1 in 10 people) include hypoglycaemia (low blood glucose levels).\u00a0<\/b><\/li>\n<\/ul>\n","protected":false},"excerpt":{"rendered":"<p>News: Novo Nordisk India announced the launch of Awiqli (insulin icodec), which the company says is the world\u2019s first once-weekly basal insulin for adults with Type 1 or Type 2 diabetes. About Awiqli About: Awiqli is the world\u2019s first once-weekly basal insulin for adults with Type 1 or Type 2 diabetes. \u00a0 Scientific name: Its&hellip; <a class=\"more-link\" href=\"https:\/\/forumias.com\/blog\/awiqli\/\">Continue reading <span class=\"screen-reader-text\">Awiqli<\/span><\/a><\/p>\n","protected":false},"author":10366,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"jetpack_post_was_ever_published":false,"footnotes":""},"categories":[1566,1738,12039],"tags":[11872,3590],"class_list":["post-367311","post","type-post","status-publish","format-standard","hentry","category-daily-factly-articles","category-science-and-technology-daily-factly-articles","category-knolls","tag-9pm-daily-factly","tag-pib","entry"],"jetpack_featured_media_url":"","views":"","jetpack_sharing_enabled":true,"_links":{"self":[{"href":"https:\/\/forumias.com\/blog\/wp-json\/wp\/v2\/posts\/367311","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/forumias.com\/blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/forumias.com\/blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/forumias.com\/blog\/wp-json\/wp\/v2\/users\/10366"}],"replies":[{"embeddable":true,"href":"https:\/\/forumias.com\/blog\/wp-json\/wp\/v2\/comments?post=367311"}],"version-history":[{"count":0,"href":"https:\/\/forumias.com\/blog\/wp-json\/wp\/v2\/posts\/367311\/revisions"}],"wp:attachment":[{"href":"https:\/\/forumias.com\/blog\/wp-json\/wp\/v2\/media?parent=367311"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/forumias.com\/blog\/wp-json\/wp\/v2\/categories?post=367311"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/forumias.com\/blog\/wp-json\/wp\/v2\/tags?post=367311"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}